Afatinib
297 PubMed studies analyzed · 29 RCTs · Evidence Score: 50.1
Research Domains
Afatinib has been studied across 10 research domains including 🔬 Oncology, 🫘 Kidney, ⏳ Longevity & Aging, 🧠 Focus & Attention, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 79% of studies addressing this area.
Loading evidence profile...
This evidence profile for Afatinib is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.